[{"address1": "7171 Frederick-Banting, Building 2", "address2": "Suite 270 St-Laurent", "city": "Montreal", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "857-412-7018", "website": "https://www.reparerx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.", "fullTimeEmployees": 129, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Zinda Ph.D.", "age": 53, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 661153, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel  Durocher Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Frank  Sicheri Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Agnel  Sfeir Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Alves", "age": 45, "title": "Senior VP & Chief Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Belanger", "title": "Executive Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Herman", "age": 45, "title": "Executive VP, Chief Commercial & Portfolio Development Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph P. O'Connell M.D.", "age": 70, "title": "Executive Vice President of Clinical Development and Medical Affairs", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.36, "open": 1.34, "dayLow": 1.31, "dayHigh": 1.39, "regularMarketPreviousClose": 1.36, "regularMarketOpen": 1.34, "regularMarketDayLow": 1.31, "regularMarketDayHigh": 1.39, "payoutRatio": 0.0, "beta": 0.842, "forwardPE": -0.45959595, "volume": 87587, "regularMarketVolume": 87587, "averageVolume": 310088, "averageVolume10days": 299480, "averageDailyVolume10Day": 299480, "bid": 0.972, "ask": 1.68, "bidSize": 2, "askSize": 2, "marketCap": 58546760, "fiftyTwoWeekLow": 0.89, "fiftyTwoWeekHigh": 4.29, "priceToSalesTrailing12Months": 1.0948026, "fiftyDayAverage": 1.15248, "twoHundredDayAverage": 2.276045, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -93043440, "profitMargins": -1.5836501, "floatShares": 22615697, "sharesOutstanding": 42510700, "sharesShort": 694214, "sharesShortPriorMonth": 1002524, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0163, "heldPercentInsiders": 0.0104, "heldPercentInstitutions": 0.77331, "shortRatio": 1.86, "shortPercentOfFloat": 0.027, "impliedSharesOutstanding": 42891400, "bookValue": 3.555, "priceToBook": 0.38396624, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -84689000, "trailingEps": -2.0, "forwardEps": -2.97, "enterpriseToRevenue": -1.74, "enterpriseToEbitda": 1.031, "52WeekChange": -0.62637365, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 1.365, "targetHighPrice": 8.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 152791008, "totalCashPerShare": 3.594, "ebitda": -90223000, "totalDebt": 1933000, "quickRatio": 6.531, "currentRatio": 6.768, "totalRevenue": 53477000, "debtToEquity": 1.279, "revenuePerShare": 1.261, "returnOnAssets": -0.26760998, "returnOnEquity": -0.46633, "grossProfits": 40099000, "freeCashflow": -44043000, "operatingCashflow": -76445000, "revenueGrowth": -1.0, "grossMargins": 0.74984, "ebitdaMargins": -1.68714, "operatingMargins": -1.72306, "financialCurrency": "USD", "symbol": "RPTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Repare Therapeutics Inc.", "marketState": "REGULAR", "regularMarketChangePercent": 0.3676467, "regularMarketPrice": 1.365, "longName": "Repare Therapeutics Inc.", "corporateActions": [], "regularMarketTime": 1746723100, "exchange": "NMS", "messageBoardId": "finmb_435208167", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1592573400000, "regularMarketChange": 0.004999995, "regularMarketDayRange": "1.31 - 1.39", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 310088, "fiftyTwoWeekLowChange": 0.47500002, "fiftyTwoWeekLowChangePercent": 0.5337079, "fiftyTwoWeekRange": "0.89 - 4.29", "fiftyTwoWeekHighChange": -2.925, "fiftyTwoWeekHighChangePercent": -0.6818182, "fiftyTwoWeekChangePercent": -62.637363, "earningsTimestamp": 1741003500, "earningsTimestampStart": 1741003500, "earningsTimestampEnd": 1741003500, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.0, "epsForward": -2.97, "epsCurrentYear": -2.11, "priceEpsCurrentYear": -0.6469195, "fiftyDayAverageChange": 0.21252, "fiftyDayAverageChangePercent": 0.18440233, "twoHundredDayAverageChange": -0.9110451, "twoHundredDayAverageChangePercent": -0.4002755, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-19", "cryptoTradeable": false, "displayName": "Repare Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]